Topics
- Key Game Changers Altering the Dynamic of the Orphan Drug Industry for Developers
- Orphan Drugs Reducing Impact of Revenue Loss from Patent Expiries of Blockbuster Drugs
- Promoting Orphan Drugs in Asia
- How Can Manufacturers Meet the Unmet Needs of Patients with Rare Diseases in the Region
- Patent Protection Be Used To Expand the Scope Of Protection
- Attract Investors and Investments into the Region
- Collaboration of Stakeholders in the Supply Chain to Ensure Accessibility of Orphan Drugs to Patients
- Right Pricing to Continue to Treat Patients and Remain Commercially Viable for Developers
- How Can R&D and Market Access Departments Pool Resources to Succeed in the Orphan Market?
- How Can Developers Access Patients with the Surmounting Number of Barriers?
- How Can Developers and Patients Collaborate to Steer the Development of Orphan Drugs?
- Reinforcing the Orphan Market for a Sustainable Future
- Ensuring the Success of the Partnership in the Orphan Market
- What Strategies are Available to Support the Development of Ultra Orphan Drugs?
Who should Attend
Representative from hospitals, government, biopharmaceuticals, pharmaceuticals, orphan drugs developers, non-profit organisations, policies, regional and local manufacturers to discuss and share on the macroeconomic factors, issues and drivers that will steer the development of orphan drugs into the region.
